BeStock  
Stocks › Biotechnology › CGEM

Cullinan Therapeutics CGEM

US equityMarket cap rank #3511Biotechnology
$8.89 −$0.18 (-1.98%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $8.96 +0.79%
Open$8.84
Prev close$9.07
Day range$8.80 – $9.46
Volume1.01M
Market cap$577.15M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts10
Average target$34.00+282.5% vs. price
  • Buy 100%
Low $27.00Now $8.89Avg $34.00High $42.00

Recent rating changes

The last 20 actions on file set price targets from $27.00 to $42.00, averaging $37.89.

DateFirmRatingTarget
10 Nov 2026 JonesTrading BUY $36.00
10 Nov 2026 BTIG BUY $41.00
9 Nov 2026 UBS BUY $27.00
9 Nov 2026 Wedbush BUY $42.00
9 Nov 2026 Stifel BUY $28.00
8 Nov 2026 BTIG BUY $41.00
5 Nov 2026 Wedbush BUY $42.00
4 Nov 2026 William Blair BUY –
4 Nov 2026 JonesTrading BUY $36.00
2 Nov 2026 BTIG BUY $41.00
27 Oct 2026 BTIG BUY $41.00
19 Oct 2026 BTIG BUY $40.00
7 Oct 2026 Wedbush BUY $42.00
6 Oct 2026 Citi BUY $33.00
2 Oct 2026 William Blair BUY –
2 Oct 2026 H.C. Wainwright BUY $35.00
1 Oct 2026 BTIG BUY $40.00
25 Sep 2026 BTIG BUY $40.00
25 Sep 2026 Wedbush BUY $42.00
25 Sep 2026 H.C. Wainwright BUY $35.00

Discussion

No comments yet — be the first to weigh in on CGEM.

Sign in to join the discussion.

Scroll to Top